Home › Pulmonary Hypertension › California › San Francisco
Pulmonary Hypertension clinical trials in San Francisco, CA
5 studies for Pulmonary Hypertension are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA020, San Francisco
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
RecruitingPhase 2
- San Francisco, San Francisco
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- University of California, San Francisco, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- University of California at San Francisco, San Francisco
Pulmonary Hypertension Association Registry
RecruitingObservational study
- UCSF Medical Center, San Francisco
- UCSF Benioff Children's Hospital, San Francisco
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Phoenix, AZ9 studies
- Cincinnati, OH8 studies
- Indianapolis, IN8 studies
- Boston, MA8 studies
- New York City, NY8 studies
- Kansas City, KS8 studies
- Rochester, MN7 studies
- Charleston, SC7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.